RE:HypotheticallyPlease look at Sedar.com
They have $750k in cash.... over the last 4Q’s the most spent was $223k
PM is running this ship lean, with the biggest variable expense being travel expense based on JCP special meetings with potential NDA clients.
They can honestly run another 3 to 9 months at current burn rate if needed. However, I know personally that management wants 2 things. First, they do not want to wait to issue a PP at the very last minute. And second, I know that PM wants to issue this at a much higher price than current share price. He understands dilution and wants the least amount of it.
I personally believe that management anticipated an earlier approval of the EPO patent.... but they are also playing with the cards dealt and dealing with he delays accordingly (see lean comment)
Furthermore, please read patent status in the May 16 MD&A in regards to the USA.. 98 % Approval with the patent answer being prepared. This goes back to Quantum Traders post in regards to the patent agents “suggestions” of how to prepare answers accordingly, and eventually getting approval or close to it.
This company can market to the United States as is.... they are choosing not to at moment because the EU Patent will make their sales pitch way easier.
Bottom line is that USA market alone (with a deal) definitely increases this share price higher...
But.... and it’s a big but (lol)... EPO market in conjunction with USA market (with a deal) increases this share price substantially more.
Chicken vs. egg here folks. I fully believe patient shareholders will be rewarded. I just don’t know how big the reward will be yet.
So I wait patiently and continue to accumulate shares as I believe this will eventually be a winner. I hope it’s a big win instead of a small win, but hey, a win is still a win!
Good Luck to All Longs,
FI4
Tobias323 wrote: Even if they do a raise for 20 000 000 units at .12 for $2.4 mill which is a lot of money! That's only 80 000 000 shares out. Big whoop.